Brief: Nova Eye Medical Says FY Revenues From Continuing Operations Up 27% To A$17.0 Million
28/08/2023 04:17
Aug 28 (Reuters) - Nova Eye Medical EYE.AX :
* FY REVENUES FROM CONTINUING OPERATIONS UP 27% TO A$17.0
MILLION
* FY NET LOSS ATTRIBUTABLE A$15.3 MILLION
Source text for Eikon: ID:nASX4S7YKJ
Further company coverage: EYE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment